STOCK TITAN

Zai Lab to Announce Second Quarter 2024 Financial Results and Recent Corporate Updates on August 6, 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is set to announce its second quarter 2024 financial results and recent corporate updates on August 6, 2024, after the U.S. markets close. The company will host a conference call and webcast on August 7, 2024, at 8:00 a.m. ET (8:00 p.m. HKT) to discuss these results. Interested participants must pre-register for the call via a provided registration link. Dial-in details will be shared upon registration, and a replay of the call will be available on the company's website shortly after the event.

Positive
  • None.
Negative
  • None.
  • Company to Host Conference Call and Webcast on August 7, 2024, at 8:00 a.m. ET (8:00 p.m. HKT)

SHANGHAI, China & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report financial results for the second quarter of 2024 and recent corporate updates, after the closing of the U.S. equity markets on Tuesday, August 6, 2024. The Company will host a live conference call and webcast on Wednesday, August 7, 2024, at 8:00 a.m. ET (8:00 p.m. HKT).

Conference Call and Webcast Information

Listeners may access the live webcast by visiting the Company's website at http://ir.zailaboratory.com. Participants must register in advance of the conference call.

Details are as follows:

Registration Link: https://register.vevent.com/register/BIaccafead4b094cf191720bf5d03048c6

All participants must use the link provided above to complete the online registration process in advance of the conference call. Dial-in details will be in the confirmation email which the participant will receive upon registering.

A replay will be available shortly after the call and can be accessed by visiting the Company's website.

About Zai Lab

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, autoimmune disorders, infectious disease, and neuroscience. Our goal is to leverage our competencies and resources to positively impact human health in China and worldwide.

For additional information about Zai Lab, including our products, business activities and partnerships, research, and other events or developments, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.

Investor Relations:

Christine Chiou / Lina Zhang

+1 (917) 886-6929 / +86 136 8257 6943

christine.chiou1@zailaboratory.com / lina.zhang@zailaboratory.com



Media:

Shaun Maccoun / Xiaoyu Chen

+1 (415) 317-7255 / +86 185 0015 5011

shaun.maccoun@zailaboratory.com / xiaoyu.chen@zailaboratory.com

Source: Zai Lab Limited

FAQ

When will Zai Lab announce its Q2 2024 financial results?

Zai Lab will announce its second quarter 2024 financial results on August 6, 2024, after U.S. markets close.

When is the Zai Lab Q2 2024 earnings call?

The Zai Lab Q2 2024 earnings call is scheduled for August 7, 2024, at 8:00 a.m. ET (8:00 p.m. HKT).

How can I register for the Zai Lab Q2 2024 earnings call?

Participants can register for the Zai Lab Q2 2024 earnings call by visiting the provided registration link.

Where can I find the replay of the Zai Lab Q2 2024 earnings call?

A replay of the Zai Lab Q2 2024 earnings call will be available on the company's website shortly after the event.

Zai Lab Limited American Depositary Shares

NASDAQ:ZLAB

ZLAB Rankings

ZLAB Latest News

ZLAB Stock Data

3.11B
996.09M
2.18%
43.86%
4.77%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SHANGHAI